Sanguinarine: An evaluation of in vivo cytogenetic activity

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 563, Issue 1, 2004, Pages 81-87

  Das, Aparajita ^a   Mukherjee, Anita ^a   Chakrabarti, J ^b  

^a UNIVERSITY OF CALCUTTA   (India)

^b Central Drugs Laboratory India   (India)

Author keywords

Chromosome aberrations; Clastogenicity; Genotoxic; Sister chromatid exchanges

Indexed keywords

SANGUINARINE; ALKALOID; ANTIINFECTIVE AGENT; BENZOPHENANTHRIDINE DERIVATIVE; DNA; ISOQUINOLINE DERIVATIVE; MUTAGENIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MARROW CELL; CELL DIVISION; CELL PROLIFERATION; CHROMATID EXCHANGE; CONTROLLED STUDY; CYTOGENETICS; DNA DAMAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; ANIMAL; CELL CYCLE; CHROMOSOME ABERRATION; DOSE RESPONSE; DRUG EFFECT; EVALUATION; HUMAN; METABOLISM; PHYSIOLOGY; SISTER CHROMATID EXCHANGE;

ARGEMONE;

ALKALOIDS; ANIMALS; ANTI-INFECTIVE AGENTS; BENZOPHENANTHRIDINES; BONE MARROW CELLS; CELL CYCLE; CHROMOSOME ABERRATIONS; DNA; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ISOQUINOLINES; MALE; MICE; MUTAGENS; SISTER CHROMATID EXCHANGE;

EID: 6044239561     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2004.06.004     Document Type: Article

References (40)

1. W.C. Evans, 2002 Pharmacognosy, 15th ed., Harcourt Publishers, London, p. 365.
2. Mitscher L.A., Drake S., Gollapudi S.R., Okwute S.K. A modern look at folkloric use of anti-infective agents. J. Nat. Prod. 50:1987;1025-1040
3. The Wealth of India, Raw Materials, vol. 11, Council for Scientific and Industrial Research, Delhi, 1976.
4. Grenby T.H. The use of sanguinarine in mouthwashes and toothpaste compared with some other antimicrobial agents. Br. Dent. J. 178:1995;254-258
5. Tenenbaum H., Dahan M., Soell M. Effectiveness of a sanguinarine regimen after scaling and root planning. J. Peridontal. 70:1999;307-311
6. Gomber S., Daral T.S., Sharma P.P., Faridi M.M. Epidemic dropsy in Trans Yamuna areas of Delhi and UP. Indian Pediatr. 31:1994;671-674
7. Singh R., Faridi M., Singh K., Siddique R., Bhatt N., Karna S. Epidemic dropsy in the eastern region of Nepal. J. Trop. Pediatr. 45:1999;8-13
8. Schmeller T., Latz-Bruning B., Wink M. Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defense against microorganisms and herbivores. Phytochemistry. 44:1997;257-266
9. Babich H., Zuckerbraun H.L., Barber I.B., Babich S.B., Borenfreund E. Cytotoxicity of sanguinarine chloride to cultured human cells from oral tissue. Pharmacol. Toxicol. 78:1996;397-403
10. Faddeeva M.D., Beliaeva T.N. Sanguinarine and ellipticine cytotoxic alkaloids isolated from well-known antitumor plants. Tsitologia. 39:1997;181-208
11. Wolff J., Knipling l. Antimicrotubule properties of benzophenanthridine alkaloids. Biochemistry. 32:1993;13334-13339
12. Mukherjee A., Agarwal K., Aguilar M.A., Sharma A. Anticlastogenic activity of beta-carotene against cyclophosphamide in mice in vivo. Mutat. Res. 263:1991;41-46
13. Sen S., Mukherjee A., Agarwal K., Sharma A. Phenethyl isothiocynate modulates clastogenicity of mitomycin C and cyclophosphamide in vivo. Mutat. Res. 371:1996;159-164
14. De A.K., Agarwal K., Mukherjee A., Sengupta D. Inhibition by capsaicin against cyclophosphamide induced clastogenicity and DNA damage in mice. Mutat. Res. 335:1995;253-258
15. Mukhopadhyay M.J., Saha A., Mukherjee A. Studies on the anticlastogenic effect of turmeric and curcumin on cyclophosphamide and mitomycin C in vivo. Food Chem. Toxicol. 36:1998;73-76
16. World Health Organization, Environmental Health Criteria 51, Guide to Short-Term Tests for Detecting Mutagenic and Carcinogenic Chemicals, WHO, Geneva, 1985, pp. 100-114.
17. Becci P.J., Schwartz H., Barnes H.H., Southard G.L. Short term toxicity studies of sanguinarine and of two alkaloid extracts of Sanguinaria Canadensis. J. Toxicol. Environ. Health. 20:1987;199-202
18. Dalvi R.R. Sanguinarine: its potential as a liver toxic alkloid present in the seeds of Argemone mexicana. Experientia. 41:1985;77-78
19. Tice R.R., Hayashi M., MacGregor J.T., Anderson D., Blakey D.H., Holden H.E., Kirsch-Volders M., Oleson F.B. Jr., Pacchierotti F., Preston R.J., Romagna F., Shimada H., Sutou S., Vannier B. Report from the working group on the in vivo mammalian bone marrow chromosomal aberration test. Mutat. Res. 312:1994;305-312
20. Preston R.J., Dean B.J., Galloway S., Holden H., McFee A.F., Shelby M. Mammalian cytogenetic assays of chromosome aberrations in bone marrow cells. Mutat. Res. 189:1987;157-165
21. McFee A.F., Lowe K., Sebastian S. Jr. Improved sister chromatid differentiation using paraffin coated bromodeoxyuridine tablets in mice. Mutat. Res. 119:1983;83-88
22. Tice R.R., Ivett J.L., McFee A.F. The effect of agent treatment time on the induction of sister chromatid exchanges in mouse bone marrow cells in vivo. Mutat. Res. 182:1987a;15-29
23. Perry P., Wolff S. New Giemsa method for the differential staining of sister chromatids. Nature. 251:1974;156-158
24. Tice R.R., Luke C.A., Shelby M.D. Methyl isothiocyanate: an evaluation of in vivo cytogenetic activity. Environ. Mutagen. 9:1987;37-58
25. Schneider E.L., Chaillet J.R., Tice R.R. In vivo BudR labeling of mammalian chromosomes. Exp. Cell Res. 100:1976;396-399
26. Ivett J.L., Tice R.R. Average generation time: a new method for analyzing cellular proliferation kinetics based on bromodeoxyuridine-dependent chromosomal differential staining patterns. Environ. Mutagen. 4:1982;358
27. Margolin B.H., Resnick M.A., Rimpo J.Y., Archer P., Galloway S.M., Bloom A.D., Zieger E. Statistical analysis for in vitro cytogenetic assays using Chinese hamster ovary cells. Environ. Mutagen. 8:1986;183-204
28. R.R. Sokal, F.J. Rohlf, Biometry, third ed., San Francisco, Freeman, 1981.
29. Vavreckova C., Gawlik I., Muller K. Benzophenanthridine alkaloids of Chelidonium majus L. inhibition of 5- and 12-lipoxygenase by a non-redox mechanism. Planta Med. 62:1996;397-401
30. Firatli E., Unal T., Onan U., Sandalli P. Antioxidative activities of some chemotherapeutics. A possible mechanism in reducing gingival inflammation. J. Clin. Peridontol. 21:1994;680-683
31. Ahmad N., Gupta S., Husain M.M., Heiskanen K.M., Mukhtar H. Differential anti proliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin. Cancer Res. 69:2000;1524-1528
32. Keller K.A., Meller D.L. Reproductive and developmental toxicological evaluation of Sanguinaria extract. J. Clin. Dent. 19:1989;59-66
33. Arnason J.T., Guerin B., Kraml B., Mehta B., Redmond R.W., Scaiano J.C. Phototoxic and photochemical properties of sanguinarine. Photochem. Photobiol. 55:1992;35-38
34. Kevekordes S., Mersch-Sundermann V., Burghaus C.M., Spielberger J., Schmeiser H.H., Arlt V.M., Dunkelberg H. SOS induction of selected naturally occurring subsatances in Escherichia coli (SOS chromotest). Mutat. Res. 445:1999;81-91
35. Kevekordes S., Spielberger J., Burghaus C.M., Birkenkamp P., Zeitz B., Paufler P., Diez M., Bolten C., Dunkelberg H. Micronucleus formation in human lymphocyctes and in the metabolically competent human hepatoma cell line Hep-G2: results with 15 naturally occurring substances. Anticancer Res. 21:2001;461-469
36. Krishna G., Nath J., Ong T. Inhibition of cyclophosphamide and mitomycin C-induced sister chromatid exchanges in mice by vitamin C. Cancer Res. 46:1986;2670-2674
37. Latt S.A., Allen J., Bloom S.E., Carrano A., Kram D., Schneider E., Schreck R., Tice R.R., Whitfield B.L., Wolf S. Sister chromatid exchanges: a report of the Gene-Tox program. Mutat. Res. 87:1983;17-62
38. Preston R.J., Au W., Bender M.A., Brewen J.C., Carrano A.V., Heddle J.A., Mc Fee A.F., Wolff S., Wassom J.S. Mammalian in vivo and in vitro cytogenetic assays: a report of the Gene-Tox program. Mutat. Res. 87:1983;143-188
39. Saran A., Srivastava S., Coutinho E., Maiti M. 1H NMR investigation of the interaction of berberine and sanguinarine with DNA. Indian J. Biochem. Biophys. 32:1995;74-77
40. Das S., Kumar G.S., Ray A., Maiti M. Spectroscopic and thermodynamic studies on the binding of sanguinarine and berberine to triple and double helical DNA and RNA structures. J. Biomol. Struct. Dyn. 20:2003;703-714